In vitro antileishmanial activity and molecular docking studies of lupeol and monostearin, isolated from Parkia biglobosa

Parkia biglobosa (Leguminosae) is used traditionally for managing leishmaniasis. However, there are no reports of the antileishmanial constituents from the plant. This study is aimed at isolating antileishmanial compounds, from the stem bark of P. biglobosa, and assessing their mechanism of action u...

Full description

Bibliographic Details
Main Authors: Thomas Osafo, Trudy Janice Philips, Abigail Kusiwaa Adomako, Lawrence Sheringham Borquaye, Edmund Ekuadzi, Regina Appiah-Opong, Rita Akosua Dickson
Format: Article
Language:English
Published: Elsevier 2023-03-01
Series:Scientific African
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2468227622003696
_version_ 1811159619640229888
author Thomas Osafo
Trudy Janice Philips
Abigail Kusiwaa Adomako
Lawrence Sheringham Borquaye
Edmund Ekuadzi
Regina Appiah-Opong
Rita Akosua Dickson
author_facet Thomas Osafo
Trudy Janice Philips
Abigail Kusiwaa Adomako
Lawrence Sheringham Borquaye
Edmund Ekuadzi
Regina Appiah-Opong
Rita Akosua Dickson
author_sort Thomas Osafo
collection DOAJ
description Parkia biglobosa (Leguminosae) is used traditionally for managing leishmaniasis. However, there are no reports of the antileishmanial constituents from the plant. This study is aimed at isolating antileishmanial compounds, from the stem bark of P. biglobosa, and assessing their mechanism of action using molecular docking studies. Bioassay-guided fractionation led to the isolation of two known compounds, lupeol and monostearin. Their structures were elucidated using their mass spectra. Using the 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymathoxyphenyl)-2-(4-sulfophenyl)-2H-tretrazolium (MTS) assay, the evaluated antileishmanial effects of lupeol (1) and monostearin (2) showed IC50 values of 164.42 and 151.99 µg/mL respectively. The antileishmanial effects of the crude extract, non-polar, mid-polar and polar fractions were determined to be 64.43, 126.25, 725.65 and 167.52 µg/mL respectively. Molecular docking studies of the two isolates within the active sites of two validated targets in the Leishmania parasite: trypanothione reductase (TR) and pteridine reductase 1 (PTR1), showed that both compounds established important interactions with key amino acid residues in both proteins. Lupeol exhibited binding affinities of -7.1 kcal/mol and -10.2 kcal/mol for TR and PTR1, respectively, better than monostearin in both cases. Our findings back the claim that P. biglobosa stem bark possesses antileishmanial effects. Furthermore, the isolates lupeol and monostearin may be partly responsible for the observed activities.
first_indexed 2024-04-10T05:44:15Z
format Article
id doaj.art-69319951e53f45f0b9e7e5e85691a497
institution Directory Open Access Journal
issn 2468-2276
language English
last_indexed 2024-04-10T05:44:15Z
publishDate 2023-03-01
publisher Elsevier
record_format Article
series Scientific African
spelling doaj.art-69319951e53f45f0b9e7e5e85691a4972023-03-06T04:16:25ZengElsevierScientific African2468-22762023-03-0119e01464In vitro antileishmanial activity and molecular docking studies of lupeol and monostearin, isolated from Parkia biglobosaThomas Osafo0Trudy Janice Philips1Abigail Kusiwaa Adomako2Lawrence Sheringham Borquaye3Edmund Ekuadzi4Regina Appiah-Opong5Rita Akosua Dickson6Department of Pharmacognosy, Faculty of Pharmacy and Pharmaceutical Sciences, Kwame Nkrumah University of Science and Technology, GhanaDepartment of Clinical Pathology, Noguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana, GhanaDepartment of Chemistry, Kwame Nkrumah University of Science and Technology, GhanaDepartment of Chemistry, Kwame Nkrumah University of Science and Technology, Ghana; Central Laboratory, Kwame Nkrumah University of Science and Technology, GhanaDepartment of Pharmacognosy, Faculty of Pharmacy and Pharmaceutical Sciences, Kwame Nkrumah University of Science and Technology, Ghana; Corresponding author at: Department of Pharmacognosy, Faculty of Pharmacy and Pharmaceutical Sciences, PMB, University Post Office, Kumasi, Ghana.Department of Clinical Pathology, Noguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana, GhanaDepartment of Pharmacognosy, Faculty of Pharmacy and Pharmaceutical Sciences, Kwame Nkrumah University of Science and Technology, GhanaParkia biglobosa (Leguminosae) is used traditionally for managing leishmaniasis. However, there are no reports of the antileishmanial constituents from the plant. This study is aimed at isolating antileishmanial compounds, from the stem bark of P. biglobosa, and assessing their mechanism of action using molecular docking studies. Bioassay-guided fractionation led to the isolation of two known compounds, lupeol and monostearin. Their structures were elucidated using their mass spectra. Using the 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymathoxyphenyl)-2-(4-sulfophenyl)-2H-tretrazolium (MTS) assay, the evaluated antileishmanial effects of lupeol (1) and monostearin (2) showed IC50 values of 164.42 and 151.99 µg/mL respectively. The antileishmanial effects of the crude extract, non-polar, mid-polar and polar fractions were determined to be 64.43, 126.25, 725.65 and 167.52 µg/mL respectively. Molecular docking studies of the two isolates within the active sites of two validated targets in the Leishmania parasite: trypanothione reductase (TR) and pteridine reductase 1 (PTR1), showed that both compounds established important interactions with key amino acid residues in both proteins. Lupeol exhibited binding affinities of -7.1 kcal/mol and -10.2 kcal/mol for TR and PTR1, respectively, better than monostearin in both cases. Our findings back the claim that P. biglobosa stem bark possesses antileishmanial effects. Furthermore, the isolates lupeol and monostearin may be partly responsible for the observed activities.http://www.sciencedirect.com/science/article/pii/S2468227622003696TriterpenesMonoglyceridesParkia clappertonianaLeishmaniasisDockingTrypanothione reductase
spellingShingle Thomas Osafo
Trudy Janice Philips
Abigail Kusiwaa Adomako
Lawrence Sheringham Borquaye
Edmund Ekuadzi
Regina Appiah-Opong
Rita Akosua Dickson
In vitro antileishmanial activity and molecular docking studies of lupeol and monostearin, isolated from Parkia biglobosa
Scientific African
Triterpenes
Monoglycerides
Parkia clappertoniana
Leishmaniasis
Docking
Trypanothione reductase
title In vitro antileishmanial activity and molecular docking studies of lupeol and monostearin, isolated from Parkia biglobosa
title_full In vitro antileishmanial activity and molecular docking studies of lupeol and monostearin, isolated from Parkia biglobosa
title_fullStr In vitro antileishmanial activity and molecular docking studies of lupeol and monostearin, isolated from Parkia biglobosa
title_full_unstemmed In vitro antileishmanial activity and molecular docking studies of lupeol and monostearin, isolated from Parkia biglobosa
title_short In vitro antileishmanial activity and molecular docking studies of lupeol and monostearin, isolated from Parkia biglobosa
title_sort in vitro antileishmanial activity and molecular docking studies of lupeol and monostearin isolated from parkia biglobosa
topic Triterpenes
Monoglycerides
Parkia clappertoniana
Leishmaniasis
Docking
Trypanothione reductase
url http://www.sciencedirect.com/science/article/pii/S2468227622003696
work_keys_str_mv AT thomasosafo invitroantileishmanialactivityandmoleculardockingstudiesoflupeolandmonostearinisolatedfromparkiabiglobosa
AT trudyjanicephilips invitroantileishmanialactivityandmoleculardockingstudiesoflupeolandmonostearinisolatedfromparkiabiglobosa
AT abigailkusiwaaadomako invitroantileishmanialactivityandmoleculardockingstudiesoflupeolandmonostearinisolatedfromparkiabiglobosa
AT lawrencesheringhamborquaye invitroantileishmanialactivityandmoleculardockingstudiesoflupeolandmonostearinisolatedfromparkiabiglobosa
AT edmundekuadzi invitroantileishmanialactivityandmoleculardockingstudiesoflupeolandmonostearinisolatedfromparkiabiglobosa
AT reginaappiahopong invitroantileishmanialactivityandmoleculardockingstudiesoflupeolandmonostearinisolatedfromparkiabiglobosa
AT ritaakosuadickson invitroantileishmanialactivityandmoleculardockingstudiesoflupeolandmonostearinisolatedfromparkiabiglobosa